METABOLIC FATE OF ^<125>I-LABELED BATROXOBIN IN RATS AND DOGS

概要

論文の詳細を見る
^<125>I-Labeled batroxobin was prepared and following its intravenous and subcutaneous administrations to rats and dogs, the blood radioactivity was determined. In the both species following the intravenous injections, the decrease in radioactivity was biexponential. Following subcutaneous administration, radioactivity became maximal at 6h and decreased in a manner similar to that of the P-phase of the intravenous injection. The blood concentration of fibrinogen in dogs was also determined. After the intravenous injection, fibrinogen became undetectable 1h later, and appeared again in the blood at 24h. After the subcutaneous injection, the decrease was not so rapid. Fibrinogen resumed its original levels at 7 day after the administration in both the routes. Radioactivity after the both injections was excreted generally in the urine in about the same amounts. The total urinary and fecal excretions in rats and dogs were 80 and 95%, respectively. The distribution of radioactivity in the tissues was examined by counting technique and whole-body autoradiography. Radioactivity predominantly accumulated in the thyroid and stomach and could also be found in the kidneys and liver in fair amounts. The distribution patterns of radioactivity for both the routes of administrations and also for male and pregnant rats were basically the same. In fetus rats, a slight distribution was noted. From the results of gel filtration chromatography and trichloroacetic acid fractionation, [^<125>I] batroxobin was metabolized soon after the administration to afford low molecular substances such as ^<125>I-ion in the plasma and urine.
日本トキシコロジー学会の論文
1986-08-25

METABOLIC FATE OF ^<125>I-LABELED BATROXOBIN IN RATS AND DOGS

スポンサーリンク

概要

著者

関連論文

スポンサーリンク